Microbiota composition in bilateral healthy breast tissue and breast tumorsOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This pilot study examined the microbiota composition of breast tissue, comparing bilateral normal breast tissue within the same women to breast tumor tissue from a separate group of women. The researchers wanted to know whether microbiota composition differed by breast side (left versus right) within individuals, and whether it differed between normal and tumor tissue. DNA was extracted from tissue samples, amplified, and sequenced, then analyzed using QIIME and RStudio to characterize bacterial taxa and diversity.
Who was studied?
Bilateral normal breast tissue samples (36 total) were collected from ten women undergoing routine mammoplasty procedures. Archived breast tumor samples (10 total) were obtained separately from a biorepository. The abstract does not provide additional demographic details such as age or health history for these women.
What were the most important findings?
Bacteroidetes, Firmicutes, Proteobacteria, and Actinobacteria were the most abundant phyla in both tumor and normal breast tissue. There were statistically significant differences in the relative abundance of various bacterial taxa between the tumor and normal groups. Alpha diversity, measured by Simpson's index, was significantly higher in normal tissue than in tumor tissue (0.968 versus 0.957, p = 0.022). Breast tumor samples also clustered distinctly from normal samples based on unweighted UniFrac measures, indicating an overall difference in microbial community structure.
What are the greatest implications of this study?
The findings support the idea that breast tissue harbors a distinct microbiome that differs between tumor and normal tissue, with tumors showing reduced bacterial diversity. This suggests specific bacterial taxa may be associated with, or influenced by, the tumor microenvironment and could warrant further investigation into a possible role in breast cancer etiology. Because this was a pilot study with a small sample, larger studies are needed to confirm which taxa are consistently associated with tumors and to clarify any causal relationship.